AMETEK, Inc. (AME): Price and Financial Metrics


Today's Latest Price: $116.84 USD

2.41 (2.11%)

Updated Dec 4 7:00pm

Add AME to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 61 in Industrial - Machinery

See all "A" rated Strong Buy stocks

AME Stock Summary

  • With a market capitalization of $26,462,059,737, Ametek Inc has a greater market value than 91.83% of US stocks.
  • With a one year PEG ratio of 2,054.12, Ametek Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 98.03% of US stocks.
  • Of note is the ratio of Ametek Inc's sales and general administrative expense to its total operating expenses; 87.98% of US stocks have a lower such ratio.
  • Stocks that are quantitatively similar to AME, based on their financial statements, market capitalization, and price volatility, are TSN, ADM, PH, MKC, and CTLT.
  • Visit AME's SEC page to see the company's official filings. To visit the company's web site, go to

AME Stock Price Chart Interactive Chart >

Price chart for AME

AME Price/Volume Stats

Current price $116.84 52-week high $121.69
Prev. close $114.43 52-week low $54.82
Day low $114.48 Volume 858,616
Day high $117.41 Avg. volume 1,359,299
50-day MA $109.46 Dividend yield 0.62%
200-day MA $93.19 Market Cap 26.88B

AMETEK, Inc. (AME) Company Bio

Ametek Inc. manufactures electronic instruments and electromechanical devices worldwide for the aerospace, power, industrials, oil, gas, petrochemical, pharmaceutical, semiconductor, factory automation, laboratory equipment, ultra precision manufacturing, medical, and test and measurement markets. The company was founded in 1930 and is based in Berwyn, Pennsylvania.

AME Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$116.84$66.59 -42%

We started the process of determining a valid price forecast for Ametek Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Ametek Inc ranked in the 36th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for AME, they are:

  • As a business, AME is generating more cash flow than 88.21% of positive cash flow stocks in the Industrials.
  • The business' balance sheet reveals debt to be 10% of the company's capital (with equity being the remaining amount). Approximately just 24.17% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • AME's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 35.71% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

ITW, NSP, NSSC, ROAD, and CSWI can be thought of as valuation peers to AME, in the sense that they are in the Industrials sector and have a similar price forecast based on DCF valuation.

AME Latest News Stream

Event/Time News Detail
Loading, please wait...

AME Latest Social Stream

Loading social stream, please wait...

View Full AME Social Stream

Latest AME News From Around the Web

Below are the latest news stories about Ametek Inc that investors may wish to consider to help them evaluate AME as an investment opportunity.

Brushless DC Motors Market | Evolving Opportunities With Allied Motion Technologies Inc. and AMETEK Inc.| Technavio

LONDON--(BUSINESS WIRE)-- #BrushlessDCMotorsMarket--The Global Brushless DC Motors Market will grow by USD 38.83 bn during 2020-2024

Business Wire | October 1, 2020

Ametek Might Become A Buy Close To 15x EV/EBITDA

AMETEK, Inc. (AME), an electrical components & equipment industry heavyweight and an S&P 500 constituent, has enjoyed strong investor attention this year despite poor sales performance impacted by the ripple effects of the pandemic. The company has an almost perfect mix of forecasted double-digit sales growth in the first half...

Vasily Zyryanov on Seeking Alpha | September 25, 2020

Fluidics for Preclinical, Life Science Research, and Clinical Applications Market: COVID-19 Business Continuity Plan | Evolving Opportunities With AMETEK Inc. and Blacktrace Holdings Ltd. | Technavio

LONDON--(BUSINESS WIRE)-- #FluidicsforPreclinicalLifeScienceResearchandClinicalApplicationsMarket--The Global Fluidics for Preclinical, Life Science Research, and Clinical Applications Market will grow by $ 1.38 bn during 2020-2024

Business Wire | September 20, 2020

Roper: Fresh Highs After The Vertafore Buy

Roper (ROP) is an underappreciated long-term value creator, one which I have provided coverage on exactly a year ago as the company was making an acquisition of a software company, as an example of its continued transformation. Given that great track record, I like to keep a close eye on...

The Value Investor on Seeking Alpha | August 14, 2020

AMETEK (AME) to Report Q2 Earnings: What's in the Offing?

AMETEK's (AME) second-quarter results are likely to reflect benefits of acquisitions and cost cutting strategies amid coronavirus pandemic.

Yahoo | July 30, 2020

Read More 'AME' Stories Here

AME Price Returns

1-mo 7.31%
3-mo 17.86%
6-mo 22.42%
1-year 19.47%
3-year 68.03%
5-year 119.50%
YTD 18.05%
2019 48.27%
2018 -5.89%
2017 49.98%
2016 -8.63%
2015 2.50%

AME Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full AME Dividend History

Continue Researching AME

Here are a few links from around the web to help you further your research on Ametek Inc's stock as an investment opportunity:

Ametek Inc (AME) Stock Price | Nasdaq
Ametek Inc (AME) Stock Quote, History and News - Yahoo Finance
Ametek Inc (AME) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8636 seconds.